Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | CMB305 placebo control | 0 | None | 0 | 0 | 0 | 0 | View |
| CMB305 | CMB305: Sequentially administered LV305 \[lentiviral vector encoding New York esophogeal squamous cell carcinoma-1 {NY-ESO-1} gene\] and G305 \[NY-ESO-1 recombinant protein plus glucopyranosyl lipid A stable emulsion {GLA-SE}\] | 0 | None | 0 | 0 | 0 | 0 | View |